ClinicalTrials.gg
Drug

Huperzine A clinical trials

studies test it
13
open now
4
in phase 3
1
first study started
2004

How each study uses huperzine A is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the huperzine A studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Huperzine A
7
Huperzine A injection
3
huperzia serrata
2

Studies by the year they started

13 studies that test it; most in 2009 (2)

Studies that test huperzine A, by start year
YearStudies
20041
20092
20102
20131
20171
20191
20201
20221
20242
20261

By phase

A phase 1/2 study counts in both.

Phase 1
4
Phase 2
3
Phase 3
1
Phase 4
4
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 6 · Other 7

Wanbangde Pharmaceutical Group Co., LTD (3) · Supernus Pharmaceuticals, Inc. (1) · Baylor College of Medicine (1) · National Institute on Aging (NIA) (1) · Shanghai Mental Health Center (1) · Second Affiliated Hospital of Wenzhou Medical University (1) · Spaulding Rehabilitation Hospital (1) · Jiangsu Famous Medical Technology Co., Ltd. (1)

Often tested with

Tested in the same studies.

Rivastigmine (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2

Studies that test huperzine A.

Studies

Open first, then newest update. How each study uses huperzine A is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 13

Given beside what is tested · 1 — huperzine A is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with huperzine A

Codes

What other systems call huperzine A · ClinicalTrials.gg INT003298

  • MeSH (NLM) C050426huperzine AConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 0111871I23HUPERZINE AConfirmed FDA, NLM, Wikidata
  • RxNorm 2267703One source FDA
  • Wikidata Q425198huperzine AConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C97271Huperzine AOne source FDA
  • DrugBank DB04864One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.